Myc inhibition triggers GM-CSF-driven regression of pancreatic tumours
Tania Campos, Roderik M. Kortlever, Nicole M. Sodir, Michael D. Buck, Julie Stockis, Jonathan Parker, CM Lam, Juan Rodrigo Patiño-Mercau, Alessandra Perfetto, Abigail R. Edwards, Stefan Boeing, TYF Halim, GI EVAN
This study shows that inhibiting Myc in pancreatic tumours triggers GM-CSF release, which drives tumour regression via cDC1s, offering a new therapeutic strategy for PDAC.
bioRxiv · Feb 25, 2026 · PreprintCancer Biology